Skip to main content
Nexalin Technology, Inc. (NXL)
NASDAQ: NXL · Real-Time Price · USD
0.370
-0.000 (-0.05%)
Apr 29, 2026, 9:41 AM EDT - Market open

Nexalin Technology Revenue

In the year 2025, Nexalin Technology had annual revenue of $301.65K with 78.78% growth. Nexalin Technology had revenue of $171.90K in the quarter ending December 31, 2025, with 532.46% growth.

Revenue (ttm)
$301.65K
Revenue Growth
+78.78%
P/S Ratio
25.25
Revenue / Employee
$50,275
Employees
6
Market Cap
7.61M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025301.65K132.93K78.78%
Dec 31, 2024168.72K57.97K52.35%
Dec 31, 2023110.75K-1.21M-91.62%
Dec 31, 20221.32M1.18M817.20%
Dec 31, 2021144.07K-98.85K-40.69%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Trinity Biotech 48.57M
Vivos Therapeutics 17.44M
Beyond Air 6.92M
Biomerica 4.33M
Tenon Medical 3.94M
Intelligent Bio Solutions 3.58M
Sintx Technologies 1.02M
Co-Diagnostics 622.49K
Revenue Rankings

NXL News

More News